Evidence map›Paper›PMID 32061633›Full record

ReviewProgress in cardiovascular diseases

Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from pathophysiology to optimize treatment.

Fabio Mangiacapra, Marco Giuseppe Del Buono, Antonio Abbate, Tommaso Gori, Emanuele Barbato, Rocco Antonio Montone, Filippo Crea, Giampaolo Niccoli

Abstract readReview
PubMed Publisher
In one paragraph

Review in Progress in cardiovascular diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Sex differences in coronary disease health Status outcomes: the ISCHEMIA trial.European heart journal. Quality of care & clinical outcomes · 2026
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in cardiovascular medicine · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Research and practice in thrombosis and haemostasis · 2023
    Article
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 3 countries.

Fabio MangiacapraUnit of Cardiovascular Science, Campus Bio-Medico University, Rome, Italy. Electronic address: f.mangiacapra@unicampus.it.
Marco Giuseppe Del BuonoDepartment of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Catholic University of the Sacred Heart, Rome, Italy.
Antonio AbbateVCU Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, United States of America.
Tommaso GoriKardiologie I, Zentrum für Kardiologie, University Medical Center Mainz and DZHK Standort Rhein-Main, Mainz, Germany.
Emanuele BarbatoDepartment of Advanced Biomedical Sciences, University of Naples, Federico II, Naples, Italy.
Rocco Antonio MontoneDepartment of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Catholic University of the Sacred Heart, Rome, Italy.
Filippo CreaDepartment of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Catholic University of the Sacred Heart, Rome, Italy.
Giampaolo NiccoliDepartment of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Catholic University of the Sacred Heart, Rome, Italy.
Agostino Gemelli University Polyclinic · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITJohannes Gutenberg University Mainz · DEUniversità Campus Bio-Medico · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Naples Federico II · ITVirginia Commonwealth University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelial dysfunction (EnD) is a hallmark feature of coronary artery disease (CAD), representing the key early step of atherosclerotic plaque development and progression. Percutaneous coronary intervention (PCI) is performed daily worldwide to treat symptomatic CAD, however a consistent proportion of patients remain symptomatic for angina despite otherwise successful revascularization. EnD plays a central role in the mechanisms of post-PCI angina, as it is strictly associated with both structural and functional abnormalities in the coronary arteries that may persist, or even accentuate, following PCI. The assessment of endothelial function in patients undergoing PCI might help to identify those patients at higher risk of future cardiovascular events and recurrent/persistent angina who might therefore benefit more from an intensive treatment. In this review, we address the role of EnD in determining angina after PCI, discussing its pathophysiological mechanisms, diagnostic approaches and therapeutic perspectives.

Indexed as

Coronary CirculationAngina PectorisCoronary Artery DiseaseCoronary RestenosisCoronary ThrombosisCoronary VasospasmCoronary VesselsEndothelium, VascularHemodynamicsHumansMicrocirculationPercutaneous Coronary InterventionRisk FactorsStentsTreatment OutcomeAnginaEndothelial dysfunctionMicrovascular dysfunctionPercutaneous coronary interventionRecurrent angina

Identifiers

PMID32061633
OpenAlexW3005997018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.